Susquehanna Fundamental Investments’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$334K Buy
12,727
+2,435
+24% +$59.4K 0.01% 1219
2021
Q4
$244K Sell
10,292
-6,038
-37% -$149K 0.01% 1181
2021
Q3
$410K Sell
16,330
-15,590
-49% -$397K 0.01% 1293
2021
Q2
$829K Sell
31,920
-7,850
-20% -$214K 0.02% 943
2021
Q1
$1.02M Buy
39,770
+750
+2% +$19.2K 0.02% 882
2020
Q4
$782K Buy
39,020
+320
+0.8% +$6.27K 0.01% 951
2020
Q3
$663K Buy
38,700
+12,300
+47% +$233K 0.02% 779
2020
Q2
$576K Buy
+26,400
New +$604K 0.03% 579

Other funds holding NTUS

Susquehanna Fundamental Investments's NTUS Position: Q1 2022 in Review

Susquehanna Fundamental Investments increased its Natus Medical Inc (NTUS) stake by 24% in Q1 2022, buying an estimated $59.4K and bringing the position to 12,727 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #1219.

Susquehanna Fundamental Investments first reported a position in NTUS in Q2 2020 and has held it in 8 quarters since. The position peaked at $1.02M in Q1 2021. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.

  • Susquehanna Fundamental Investments held 12,727 shares of Natus Medical Inc worth $334K as of Q1 2022.
  • Susquehanna Fundamental Investments bought 2,435 Natus Medical Inc shares in Q1 2022, an estimated $59.4K.
  • Natus Medical Inc made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1219 holding.
  • Susquehanna Fundamental Investments first reported a position in Natus Medical Inc in Q2 2020 and has held it in 8 quarters since.
  • Susquehanna Fundamental Investments's Natus Medical Inc position peaked at $1.02M in Q1 2021.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.